Blackmores (ASX:BKL) complete the divestment of Global Therapeautics

Company News

by Rachael Jones

Blackmores (ASX:BKL) have completed the divestment of Global Therapeautics to McPherson’s.

A Business Sale Agreement was announced on the 27th October.

Blackmores Chief Executive Officer Alastair Symington said, “We expect Global Therapeutics will flourish as a key business within McPherson’s Health Division.

Shares in Blackmores (ASX:BKL) closed 1.01 per cent lower at $79.19 yesterday.